Please login to the form below

Not currently logged in
PMLiVE Top Pharma List

Data by

Global Data


Revenue 2014


The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Takeda's 2013 sales performance.

Japanese pharma pulls no punches with post-Brexit UK

Japanese pharma pulls no punches with post-Brexit UK

Takeda - notes that all its members conduct R&D in the UK and over £60m was invested by them directly in the country last year. ... For example, in October, Takeda announced a cancer collaboration with Crescendo Biologics, which could be worth nearly

FDA won't add outcomes data to Januvia label

FDA won't add outcomes data to Januvia label Those concerns have caused warnings to be imposed on some rival drugs, namely AstraZeneca's Onglyza (saxagliptin) and Takeda's Nesina (alogliptin).

Microbiome specialist Rebiotix chalks up C. diff trial success

Microbiome specialist Rebiotix chalks up C. diff trial success Takeda has been actively seeking out companies working in this area - forging deals with Enterome (which is also working with Bristol-Myers Squibb), Finch Therapeutics and most recently NuBiyota to build

Deal Watch February 2017

Deal Watch February 2017 Deal Watch February 2017. Actelion, Johnson &Johnson, Sanofi, Takeda and more feature in this month's pharma deals round-up.

Roche’s Alecensa beats Xalkori as first-line lung cancer therapy

Roche’s Alecensa beats Xalkori as first-line lung cancer therapy It competes in the second-line setting with Novartis' Zykadia (ceritinib), and later this year could see another rival in the form of Takeda's brigatinib, acquired along with Ariad in

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global revenue 2014
1: Novartis
2: Pfizer
3: Roche
4: Sanofi
5: Merck & Co.
6: Johnson & Johnson
7: GlaxoSmithKline
8: AstraZeneca
9: Gilead Sciences
10: Takeda
11: AbbVie
12: Amgen
13: Teva
14: Lilly
15: Bristol-Myers Squibb
16: Bayer
17: Novo Nordisk
18: Astellas
19: Boehringer Ingelheim
20: Actavis
21: Otsuka
22: Daiichi Sankyo
23: Biogen Idec
24: Baxter
25: Merck KGaA
Japan revenue 2014
1: Takeda
2: Otsuka
3: Meiji
4: Astellas
5: Daiichi Sankyo
6: Teijin
7: Eisai
8: Chugai
9: Mitsubishi Tanabe
10: Kyowa Hakko Kirin
11: Taisho
12: Shionogi
13: Hisamitsu
14: Santen
15: Ono
16: Kyorin
17: Nichi-Iko
18: Mochida
19: Sawai
20: Kaken
21: Kissei
22: Zeria
23: Towa
24: Torii
25: Daito
Oncology revenue 2014
1: Roche
2: Novartis
3: Celgene
4: Johnson & Johnson
5: Bristol-Myers Squibb
6: Lilly
7: Takeda
8: AstraZeneca
9: Merck & Co.
10: Amgen
11: Pfizer
12: Astellas
13: Bayer
14: Otsuka
15: Sanofi
16: Merck KGaA
17: Eisai
18: AbbVie
19: Pharmacyclics
20: Incyte
Immunology revenue 2014
1: AbbVie
2: Johnson & Johnson
3: Pfizer
4: Amgen
5: Merck & Co.
6: Astellas
7: Roche
8: Novartis
9: Bristol-Myers Squibb
10: Mitsubishi Tanabe
11: UCB
12: Hisamitsu
13: Daiichi Sankyo
14: Takeda
Cardiovascular revenue 2014
1: AstraZeneca
2: Sanofi
3: Merck & Co.
4: Daiichi Sankyo
5: Pfizer
6: Novartis
7: Bayer
8: Takeda
9: Boehringer Ingelheim
10: Astellas
11: Actelion
12: Johnson & Johnson
13: Shionogi
14: United Therapeutics
15: Bristol-Myers Squibb
16: Gilead Sciences
17: Otsuka
18: Roche
19: Lilly
20: The Medicines Company
Metabolic revenue 2014
1: Novo Nordisk
2: Sanofi
3: Merck & Co.
4: Lilly
5: AstraZeneca
6: Takeda
7: Novartis
8: Amgen
9: Bayer
10: Merck KGaA
11: Salix Pharmaceuticals
12: AbbVie
13: Dainippon Sumitomo Pharma
14: Kyowa Hakko Kirin
15: Mitsubishi Tanabe

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit

Featured jobs

Subscribe to our email news alerts


Add my company
CAN advertising

Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...

Latest intelligence

Bowel Cancer Awareness Month
Synergy Vision are supporting Bowel Cancer Awareness Month. Bowel cancer is one of most common cancers diagnosed in the UK, but with early diagnosis and treatment, most cases can be...
The right way to capture customer data
Digital communication should be a two-way process with information flowing backwards and forwards between you and healthcare professionals. That digital technology enables HCPs to give feedback is a big part...
Can you access your own content?
The rapid development of multichannel communication opens new opportunities to provide high-value experiences for healthcare professionals and gives you more places than ever to tell your product story. But unless...